Premium
Differential Hm antigen expression on EC cells and early differentiated derivatives.
Author(s) -
Simmler M.C.,
Avner P.R.
Publication year - 1985
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1002/j.1460-2075.1985.tb03757.x
Subject(s) - biology , cell culture , splenocyte , microbiology and biotechnology , priming (agriculture) , in vitro , antigen , ctl* , immunogenicity , immunology , cytotoxic t cell , genetics , germination , botany
Differences in the expression of minor histocompatibility (Hm) alloantigens on two mouse embryonal carcinoma (EC) cell lines and the PYS‐2 and T.D.M.‐1 differentiated derivatives have been demonstrated by their ability to elicit a cytolytic T‐lymphocyte (CTL) response. Experiments involving the use of various responder‐target strain combinations on the one hand and Recombinant Inbred (RI) mice strains on the other have shown that: (i) there are major differences in Hm expression on the EC cells compared with the differentiated derivatives whose Hm expression appears more akin to that of adult splenocytes; (ii) although both EC cell lines show reduced Hm immunogenicity compared with adult splenocytes, major differences in the expression and possibly presentation between the F9 and PCC3 EC cell lines can be detected both by in vivo priming and by in vitro cold competition target experiments. These results are discussed in connection with the unexpected finding that some EC cell lines are capable of specific competition effects for appropriate CTL effectors despite their inability to stimulate such effectors in vitro and the absence of major histocompatibility complex (MHC) products.